Radiopharm Theranostics Statistics

Total Valuation

ASX:RAD has a market cap or net worth of AUD 52.03 million. The enterprise value is 14.39 million.

Market Cap	52.03M
Enterprise Value	14.39M

Important Dates

The next estimated earnings date is Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:RAD has 2.36 billion shares outstanding. The number of shares has increased by 243.78% in one year.

Current Share Class	2.36B
Shares Outstanding	2.36B
Shares Change (YoY)	+243.78%
Shares Change (QoQ)	+327.30%
Owned by Insiders (%)	10.76%
Owned by Institutions (%)	5.66%
Float	1.60B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	157.36
PB Ratio	1.00
P/TBV Ratio	10.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.33
EV / Sales	43.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.37

Current Ratio	3.37
Quick Ratio	3.25
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-59.53

Financial Efficiency

Return on equity (ROE) is -112.21% and return on invested capital (ROIC) is -59.05%.

Return on Equity (ROE)	-112.21%
Return on Assets (ROA)	-28.95%
Return on Invested Capital (ROIC)	-59.05%
Return on Capital Employed (ROCE)	-45.48%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, ASX:RAD has paid 166,113 in taxes.

Income Tax	166,113
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.54% in the last 52 weeks. The beta is 0.83, so ASX:RAD's price volatility has been lower than the market average.

Beta (5Y)	0.83
52-Week Price Change	-40.54%
50-Day Moving Average	0.02
200-Day Moving Average	0.03
Relative Strength Index (RSI)	44.92
Average Volume (20 Days)	1,627,044

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:RAD had revenue of AUD 330,628 and -43.00 million in losses. Loss per share was -0.04.

Revenue	330,628
Gross Profit	-21.38M
Operating Income	-36.07M
Pretax Income	-42.67M
Net Income	-43.00M
EBITDA	-32.99M
EBIT	-36.07M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 36.44 million in cash and n/a in debt, giving a net cash position of 36.44 million or 0.02 per share.

Cash & Cash Equivalents	36.44M
Total Debt	n/a
Net Cash	36.44M
Net Cash Per Share	0.02
Equity (Book Value)	52.00M
Book Value Per Share	0.02
Working Capital	31.21M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-33.42M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-10,908.64%
Pretax Margin	-12,905.05%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:RAD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-243.78%
Shareholder Yield	n/a
Earnings Yield	-82.65%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:RAD has an Altman Z-Score of -2.23 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.23
Piotroski F-Score	2